Business
MedX Health Corp. appoints Steve Guillen as new President and Director
Seasoned medical technology executive to lead Company into next stage of growth MISSISSAUGA, ON, ...
About this update from Medx Health Corp.
[{"type":"text","content":"\n\n\n\nSeasoned medical technology executive to lead Company into next stage of\n\n\ngrowth\n\n\nMISSISSAUGA, ON, April 4 /CNW/ - MedX Health Corp. (TSXV: MDX) ("MedX" or\nthe "Company") is pleased to announce the appointment of Mr. Steven T. Guillen\nas President and Director of MedX, replacing Phil Passy, MedX's founder, who\npassed away recently, shortly after MedX completed a $4.0 million public\noffering.\n\n\n"On behalf of the Board, I would like to welcome Steve Guillen to MedX,"\nsaid Gary Van Nest, MedX's Chairman. "Steve is a leader of the highest\ncaliber, with extensive experience and a proven track record in the health\ncare industry. Of particular note is the fact that Steve has experience in the\nareas of sales & marketing and mergers & acquisitions, both of which are areas\nwe feel will be important to MedX's future success. Beyond that, Steve's\nproven ability to lead a company through change, to develop strategies to\nre-invigorate growth, to effectively execute those strategies and to\ncommunicate all of this to the public equity capital markets, all make Steve a\nuniquely qualified candidate for the position."\n\n\nMost recently, Mr. Guillen was, for two years, Chief Executive Officer of\nOXIS International, Inc. (OTC BB:OXIS.OB), where he was recruited to lead, and\nturn around, an asset-rich publicly traded company with products in\ndiagnostics, therapeutics, and nutraceuticals. He directed commercial strategy\nand grew revenues from $2M to $6M in his first year. He also directed an\nacquisition and the subsequent merger of the two organizations, including the\nrelocation of operations and integration of manufacturing, finance, R&D, and\nSales & Marketing into one site, thereby improving both revenues and\nprofitability. Prior to that, Mr. Guillen was, for eight years, Vice President\nof Sales & Marketing for Amarin Pharmaceuticals, based in Mill Valley,\nCalifornia, and Athena Diagnostics, based in Boston, Massachusetts. Prior to\nthat, he had a number of different roles of increasing responsibility within\nMerck & Co, before he was recruited to establish the initial commercial\norganization for Athena Neurosciences, as their first Director of Sales.\n\n\n"I couldn't be more excited about joining MedX," said Mr. Guillen. "The\n...